Trending:
News
-
20 February 2019
Empatica and DRIVe to work on smartwatch to predict lung infections
Empatica, a Massachusetts Institute of Technology (MIT) Media Lab spin-off, has collaborated with the US BARDA Division of Research, Innovation and Ventures (DRIVe) to develop a new smartwatch to predict...
-
20 February 2019
BGU develops new AI platform to track neurodegenerative disorders
BGN Technologies, the technology transfer company of Israel-based Ben-Gurion University (BGU), has unveiled a new artificial intelligence (AI) platform to monitor and predict the progression of neurodegenerative diseases.
-
19 February 2019
Qiagen and Ares Genetics to develop bioinformatics and assay solutions
Assay technologies provider Qiagen has partnered with molecular diagnostics developer Ares Genetics for the development of new bioinformatics and assay solutions to deal with antibiotic-resistant pathogens.
-
19 February 2019
Medtronic-funded study provides OIRD risk prediction tool
Medtronic has reported preliminary results from the Microstream Capnography Study that provided an easy-to-use risk prediction tool for opioid-induced respiratory depression (OIRD).
-
19 February 2019
Philips unveils new Zenition mobile C-arm imaging platform
Royal Philips has unveiled its new Zenition mobile C-arm imaging platform, which can provide live image guidance during surgical procedures.
-
18 February 2019
PET/CT imaging agent could improve acute venous thromboembolism diagnosis
Researchers based at the University of Ulsan College of Medicine in the Republic of Korea have found that the positron emission tomography/computed tomography (PET/CT) tracer 18F-GP1 results in high image...
-
18 February 2019
Researchers develop electrode for less invasive neural stimulation
A research team at the University of Pittsburgh in the US has developed a new electrode to facilitate less invasive neural stimulation for the treatment of neurological conditions such as...
-
18 February 2019
Hologic secures two CE-Marks for Aptima HIV-1 Quant Dx Assay
Hologic has received two new CE-Marks for its Aptima HIV-1 Quant Dx Assay in early infant diagnosis (EID) and to test dried blood spots (DBS) in Europe.
-
18 February 2019
US regulator seeks additional details on $4.2bn Boston Scientific-BTG deal
The US Federal Trade Commission (FTC) has requested for additional information and documentary material from Boston Scientific and BTG on their proposed $4.2bn acquisition deal.
-
15 February 2019
Artificial intelligence predicts ovarian cancer patients’ survival rate
Researchers from Imperial College London and the University of Melbourne have created artificial intelligence (AI) software that can predict the prognosis of ovarian cancer patients more accurately than current methods...